Arbutus Biopharma Corp Quarterly Nonoperating Income (Expense) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Arbutus Biopharma Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2014 to Q3 2024.
  • Arbutus Biopharma Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.72M, a 18.5% increase year-over-year.
  • Arbutus Biopharma Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $6.43M, a 44.6% increase year-over-year.
  • Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2023 was $5.25M, a 1083% increase from 2022.
  • Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2022 was $444K.
  • Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2021 was -$2.73M, a 54.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.43M $1.72M +$269K +18.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $6.16M $1.79M +$496K +38.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.67M $1.49M +$414K +38.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $5.25M $1.44M +$805K +128% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $4.45M $1.45M +$1.21M +496% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $3.24M $1.29M +$1.37M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.87M $1.07M +$1.42M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $444K $630K +$1.16M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$711K $244K +$994K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$1.71M -$83K +$662K +88.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$2.37M -$347K +$358K +50.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$2.73M -$525K +$216K +29.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$2.94M -$750K +$2.79M +78.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$5.73M -$745K +$201K +21.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$5.93M -$705K +$9K +1.26% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$5.94M -$741K +$10.9M +93.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$16.8M -$3.54M +$596K +14.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$17.4M -$946K +$1.72M +64.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$19.1M -$714K +$3.34M +82.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$22.5M -$11.6M -$10.3M -763% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$12.2M -$4.13M -$7.81M -213% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$4.4M -$2.67M -$27.8M -111% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $23.4M -$4.06M -$5.03M -515% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $28.4M -$1.35M -$1.34M -67200% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $29.8M $3.67M +$2.37M +183% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $27.4M $25.1M +$23.9M +1944% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $3.5M $976K +$1.3M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $2.2M -$2K +$1.39M +99.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $805K $1.3M +$1.92M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$1.11M $1.23M +$846K +220% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$1.96M -$328K -$4.43M -108% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $2.47M -$1.39M -$6.9M -125% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $9.37M -$620K -$14.6M -104% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $24M $384K +$850K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $23.1M $4.1M -$1.91M -31.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $25M $5.51M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $14M +$15.7M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$466K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $6.02M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q3 2014 -$1.76M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.